2198 articles by Nick Paul Taylor
-
Abbott recalls Freestyle Libre 3 sensors due to incorrect glucose readings
July 26, 2024 -
AI’s expert-level image analysis can be built on flawed rationales: study
July 25, 2024 -
Owens & Minor inks $1.36B takeover of Rotech
July 25, 2024 -
Inspire Medical chief operating officer leaving to take CEO role
July 25, 2024 -
Top 5 medtech deals in the first half of 2024
July 24, 2024 -
Cook Medical to sell reproductive health business to private equity firm
July 23, 2024 -
Guardant settles allegations it violated the False Claims Act
July 23, 2024 -
FDA sends 2 warning letters after inspecting Chinese syringe manufacturers
July 22, 2024 -
Truvian raises $74M to bring blood test instrument to market
July 22, 2024 -
GE Healthcare to buy AI software from Intelligent Ultrasound for $51M
July 19, 2024 -
Danaher setting up labs to support companion diagnostic development
July 18, 2024 -
Quest closing Pennsylvania lab, laying off 121 people
July 17, 2024 -
FDA creates communication ‘super office’ at CDRH
July 16, 2024 -
J&J, Abbott and Intuitive start medtech earnings season
July 16, 2024 -
House committee tells FDA to suspend lab developed test rule
July 15, 2024 -
Hamilton recalls ventilators that may fail to restart
July 15, 2024 -
Element raises $277M to challenge Illumina in sequencing market
July 12, 2024 -
FDA finalizes guidance on studying opioid use disorder treatments
July 12, 2024 -
FDA warns BD blood culture bottle shortage could impact diagnosis
July 11, 2024 -
Medtronic recalls endotracheal tubes over blockage risk
July 11, 2024 -
Roche wins CE mark for its first CGM
July 10, 2024 -
Illumina buys Fluent Biosciences, adding single-cell analysis tech
July 10, 2024 -
Pulse drops 510(k) plan for PFA device after FDA requests clinical data
July 9, 2024 -
Masimo offered up to $950M for consumer business
July 9, 2024 -
BD to close Ireland facility, putting 170 jobs at risk
July 8, 2024